European Food Safety Authority • Via Carlo Magno 1A • 43126 Parma • ITALY Tel. +39 0521 036 111 • Fax +39 0521 036 110 • www.efsa.europa.eu

Workshop: Strengthening regional cooperation in South East

Europe and Middle East for prevention and control of Lumpy Skin Disease (LSD)

Meeting date: 11-12 May 2016

Meeting venue: Rue Froissart 36, 1040 Brussels,

Belgium

Meeting room: Albert Borschette Congress Center

Room 4A

Meeting hours: 11 May 2016, 09:00 – 18:00

12 May 2016, 09:00 – 15:30

Agenda

Introduction: This workshop is organised by EFSA in cooperation with DG SANTE, and funded by the European Commission (EC) under the EFSA Pre-Accession Programme 2015-2017 (Programme). The overall objective of the Programme is to promote the understanding of EFSA’s work, share expertise and create information exchange mechanisms.

Aim of the workshop: The aim of the workshop is to increase the awareness on the epidemiological situation of LSD and to improve cooperation at regional level for LSD surveillance, prevention and control by:

- establishing synergies; - identifying specific needs and possible instruments to satisfy them; - sharing of best practices; - preparing a list of shared recommendations valid for LSD and other transboundary

diseases. Invited:

- Representatives from European and other Mediterranean countries where LSD is of particular concern: Albania, Bosnia and Herzegovina, Bulgaria, Cyprus, Greece, Israel, Jordan, Kosovo*, Lebanon, Montenegro, Serbia, the former Yugoslav Republic of Macedonia and Turkey

- Representatives from EFSA, EC (DG SANTE), OIE Reference Laboratory on capripoxviruses, REMESA secretariat, CODA -CERVA

Language: English

11 May 2016, Chair Alessandro BROGLIA, Scientific Officer, Animal and Plant Health Unit,

EFSA

09.00– 09.15 Welcome by the Chair Introduction to the workshop EFSA and EC

09.15– 09.45 Update on epidemiology of LSD – evidence from 2015 onwards and highlight current knowledge gaps Eeva TUPPURAINEN, Private veterinary consultant, Veterinary Expertise for Controlling Lumpy skin disease, Sheep pox and Goat pox

*This designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on

the Kosovo Declaration of Independence.

2

09.45– 10.15 Update on diagnostics - evidence from 2015 onwards Pip BEARD, OIE Reference Laboratory on capripoxviruses

10.15– 10.45 Coffee break

10.45– 11.15 Update on control measures, vaccines – evidence from 2015 onwards Eyal KLEMENT , Professor of Epidemiology and Public Health, Koret School of Veterinary Medicine

11.15 – 11.45 Presentation of results of questionnaire previously distributed Alessandro BROGLIA, Scientific Officer, Animal and Plant Health Unit, EFSA

11.45 – 12.15 Discussion on the scientific topics

12.15 – 13.15 Lunch break

13.15 - 15.25 Contributions from the affected countries (20min each): - Bulgaria - Cyprus - Greece - Israel - Jordan - Lebanon - Turkey

Lessons learnt for LSD control and identification of needs for improvement

15.25 – 15.40 Risk factors of LSD in N. Africa/Middle East Alessandro RIPANI, Veterinary officer, REMESA secretariat (teleconference call)

15.40– 16.00 Coffee break

16.00 – 16.30 Lumpy skin disease vaccine evaluation using an optimized infection model: preliminary results, Kris de CLERCQ, Veterinary Scientist, CODA-CERVA

16.30-17.30 Contributions from the non - affected countries (10 min each): - Albania - Bosnia and Herzegovina - Kosovo* - Montenegro - Serbia - the former Yugoslav Republic of Macedonia - Russian Federation (to be confirmed)

Surveillance system and preventive measures in place and identification of needs for improvement

17.30 -17.40 Contribution by ERAN RAIZMAN, DVM, PhD, ACVPM, Senior Animal Health Officer, Head of Emergency Prevention System/Animal Health Animal Health Service C-522, Food and Agriculture Organization of the United Nations

17.40– 17.50 Discussion

17.50 – 18.00 Wrap up and preparation of key message for the second day of workshop

3

12 May 2016, Chair European Commission (SANTE)

09.00-09.30 Introduction of the second day of workshop and report of key messages from first day (EFSA, EC 30 min)

9.30-9.50 Current and potential future EU policy on LSD

DILAVERIS Dimitrios, Veterinary Legislative Officer, European

Commission (SANTE)

09.50 – 12.30 (including 30 min coffee break)

CVO Tour – de - Table with CVOs on possible regional approach and synergies to control LSD (Chairing EC)

12.30-13.40 Lunch break

13.40-15.30 Wrap up and definition of key conclusions and recommendations

15.30 End of the day